Portfolio Update

Finsbury Worldwide Pharm Tst PLC
04 April 2006



                                                                    4 April 2006





                     FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC

                                    (the 'Company')


                          QUARTERLY STATEMENT OF INVESTMENTS





In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii),
the Company discloses the following:



  • Investments valuing greater than 5% of the Company's gross assets comprise
    the following:


Company Name                                                        Value of Investment at      % of Total
                                                                        31 March 2006       Portfolio  Assets
                                                                       
Novartis CHF 0.50 Regd                                                    31,802,250               8.44
Genentech Inc Com Stk USD 0.02 NPV                                        23,873,570               6.34
Wyeth Com USD 0.333                                                       19,916,543               5.29





  • The ten largest investments held by the Company comprise the following:


Company Name                                                         Value of Investment at      % of Total
                                                                         31 March 2006       Portfolio Assets
                                                                   

Novartis CHF 0.50 Regd                                                     31,802,250               8.44
Genentech Inc Com Stk USD 0.02 NPV                                         23,873,570               6.34
Wyeth Com USD 0.333                                                        19,916,543               5.29
Lilly (Eli) & Company Com USD NPV                                          18,331,844               4.87
Amgen Com USD 0.0001                                                       17,825,228               4.73
Johnson & Johnson Com USD1                                                 16,592,730               4.41
Serono SA 'B' CHF 25                                                       16,005,294               4.25
Gen-Probe Inc USD 0.0001                                                   15,571,070               4.13
Pfizer Com USD 0.05                                                        14,970,246               3.97
Medimmune Inc Com USD 0.01                                                 14,509,262               3.85







                                    - ENDS -



For further information please contact:

Tracey Lago, Company Secretary

Close Finsbury Asset Management Limited

Telephone: [phone]


                      This information is provided by RNS
            The company news service from the London Stock Exchange